QUAD Investment Management

Total investments

19

Average round size

40M

Portfolio companies

14

Rounds per year

1.27

Lead investments

2

Follow on index

0.26

Exits

2

Stages of investment
Private Equity
Areas of investment
BiotechnologyDrug DiscoverySoftwareHealth CareSmall and Medium BusinessesMedical DeviceMedicalPharmaceuticalTherapeuticsConsumer Reviews

Summary

QUAD Investment Management appeared to be the VC, which was created in 2009. The venture was found in Asia in South Korea. The main department of described VC is located in the Seoul.

For fund there is a match between the location of its establishment and the land of its numerous investments - South Korea. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Credit Bureau, Management Information Systems. Among the various public portfolio startups of the fund, we may underline ABL Bio, Vedanta Biosciences, Oncorus The fund has exact preference in some founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2019.

Besides them, we counted 5 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the QUAD Investment Management, startups are often financed by DSC Investment, Symbiosis Group, SunStates Fund. The meaningful sponsors for the fund in investment in the same round are Shinhan Private Equity, SV Investment Partners, IMM Investment.

Show more

Investments analytics

Analytics

Total investments
19
Lead investments
2
Exits
2
Rounds per year
1.27
Follow on index
0.26
Investments by industry
  • Biotechnology (11)
  • Health Care (7)
  • Medical (5)
  • Therapeutics (5)
  • Medical Device (4)
  • Show 27 more
Investments by region
  • United States (8)
  • South Korea (9)
  • Singapore (2)
Peak activity year
2019

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
8
Avg. valuation at time of investment
55M
Group Appearance index
1.00
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
HoneyNaps 07 May 2024 Health Care, Medical Device, Personal Health Early Stage Venture 11M Seoul, Seoul-t'ukpyolsi, South Korea
Korea Credit Data 17 May 2019 Software, Financial Services, Information Technology, Small and Medium Businesses, Big Data, Business Intelligence, Credit Bureau, Management Information Systems, Consumer Reviews Early Stage Venture 4M South Korea, Gyeonggi-do

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.